Eosinophilic bronchitis: clinical manifestations and implications for treatment
about
Inhaled corticosteroids for subacute and chronic cough in adultsInhaled corticosteroids for subacute and chronic cough in adultsCough: are children really different to adults?Airway wall expression of OX40/OX40L and interleukin-4 in asthmaUsefulness of Biomarkers in Work-Related Airway Disease.Eosinophilic bronchitis without asthma.Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma?Reduced pH and chloride levels in exhaled breath condensate of patients with chronic cough.Cough. 4: Cough in asthma and eosinophilic bronchitis.Eosinophilic pneumonias.Utility of signs and symptoms of chronic cough in predicting specific cause in children.The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and childrenChronic cough: state-of-the-art review.Unusual asthma syndromes and their managementGastroesophageal reflux-associated chronic cough in an adolescent and the diagnostic implications: a case report.Pharmacotherapy of cough-variant asthma.The use of exhaled nitric oxide in the management of asthma.Chronic cough - occupational considerations.An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.Controversies in the evaluation and management of chronic cough.Therapy for cough: where does it fall short?Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor.The investigation of severe asthma to define phenotypes.Role of PGE2 in asthma and nonasthmatic eosinophilic bronchitis.Cough variant asthma and atopic cough.Targeting interleukins to treat severe asthma.Eosinophilic phenotypes of airway disease.Immunobiology of critical pediatric asthma.Clinical and biological markers of asthma control.Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications.Atopic features of cough variant asthma and classic asthma with wheezing.Occupational eosinophilic bronchitis in a foundry worker exposed to isocyanate and a baker exposed to flourCough and Asthma.The relationship between the Leicester cough questionnaire, eosinophilic airway inflammation and asthma patient related outcomes in severe adult asthma.Longitudinal decline in pulmonary function in atopic cough and cough variant asthma.Attenuating effect of H+K+ATPase inhibitors on airway cough hypersensitivity induced by allergic airway inflammation in guinea-pigs.Clinical benefit of sequential three-step empirical therapy in the management of chronic cough.Respiratory symptoms, bronchial hyper-responsiveness, and eosinophilic airway inflammation in patients with moderate-to-severe atopic dermatitis.Why is eosinophilic bronchitis not asthma?The Natural Course of Atopic Dermatitis and the Association with Asthma.
P2860
Q24200175-A512F3E6-22B6-4929-B03B-1C83BA5445B1Q24234786-2C6A5AA6-6E15-4B2F-899C-A3905501E973Q24813220-A98676CF-22C0-4896-9BAB-2E85B20C44C9Q33776845-E0F03D1B-9A47-425B-AB7A-C3B3AF7EB3AFQ33845309-C8DA514C-7A60-47EA-AFB7-04732D4FB554Q34774923-7E3CB597-693A-4B2C-8A74-2E0FEC25168CQ35535436-17BC91D1-B5AE-4962-9A4B-2E4106262C3FQ35536817-CB6D0A97-28E4-41DF-915C-DBD11540517AQ35615653-056DA3B5-EF47-4FF7-A2DB-83D7995EF931Q36149065-CBD12B2F-0F61-4B0E-8A7A-40ADB9DD0D96Q36184146-70C3C35F-2A3A-47E7-A478-DBADA02C5A93Q36422663-1F4E531A-2533-44C8-9701-6498F90F05CBQ36431531-A8DBA508-FD0B-4A99-B902-3AB5BCC8A23BQ36443760-86E33B28-2E8A-4B0D-9849-9B3A6834236DQ36791721-25215BE1-9143-40DE-B41B-E385EE2B2EE3Q37000750-A2C05331-9697-4C0F-9088-FA8D9EDEF7D6Q37261439-B9F8BF3B-3631-4644-9A4F-5B3CE4E986E9Q37333395-23EB8890-E91D-42EC-A0AA-EFCB263F6520Q37522916-455C4A9A-A8AE-41D2-B980-7518B9B512F8Q37819569-230FFA57-9375-4774-9FA6-6C8827E8CF52Q37920894-50BC4C58-F85C-4668-95EB-C823735AB2D8Q37957225-65CD2E8E-2060-4492-91E0-2CD2CF7AA95AQ38003661-0CE45DE5-EBF7-4E23-96D2-BD608CEAD1E4Q38005107-830F27CA-F6B9-41A1-8B9F-7264569C4F80Q38041714-D5379F63-5898-42A4-8A05-3E08E548DBCDQ38042721-D689BFFD-6037-4E43-B15F-DE65C0D3669EQ38169241-58119D3F-1DF3-47C7-AA7A-A53F1EEBE051Q38181015-65E49A1A-30BB-4AFB-971D-651FBA408ED0Q38253224-9FF0D2E8-6DFD-41DC-94F1-C955ECCEBE01Q39063083-D1F939CC-6058-43AE-8C56-AF4781DDAE6DQ40163063-117BE059-B86B-4844-9C42-5D7C31BE80EAQ40602160-E84D6AB0-A0B5-4EEC-AEAE-CD44CAB045A8Q41960313-BCBD3FC4-C59D-4ABB-9533-A6DD0FB7CEDBQ42318567-24026F24-4517-467B-AEBD-6A1DD2D8BCAEQ44444612-93B347D8-9396-490F-9F35-E6FD4B5236AFQ46397674-333203E6-C100-4FB4-A112-0331A96F8523Q46654960-9788858A-40A7-47AF-B6F0-89245EFDA179Q46909391-636AEE29-B23C-46F1-B313-C5E37BB6A3A7Q47283832-4BEEF728-B66E-4D91-A458-7124F8AF0021Q48003548-06D28DD4-95FB-4955-9C64-DE12076B5AA0
P2860
Eosinophilic bronchitis: clinical manifestations and implications for treatment
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Eosinophilic bronchitis: clinical manifestations and implications for treatment
@ast
Eosinophilic bronchitis: clinical manifestations and implications for treatment
@en
Eosinophilic bronchitis: clinical manifestations and implications for treatment
@nl
type
label
Eosinophilic bronchitis: clinical manifestations and implications for treatment
@ast
Eosinophilic bronchitis: clinical manifestations and implications for treatment
@en
Eosinophilic bronchitis: clinical manifestations and implications for treatment
@nl
prefLabel
Eosinophilic bronchitis: clinical manifestations and implications for treatment
@ast
Eosinophilic bronchitis: clinical manifestations and implications for treatment
@en
Eosinophilic bronchitis: clinical manifestations and implications for treatment
@nl
P2860
P356
P1433
P1476
Eosinophilic bronchitis: clinical manifestations and implications for treatment
@en
P2093
P2860
P304
P356
10.1136/THORAX.57.2.178
P407
P577
2002-02-01T00:00:00Z